47351-017 : Cladribine 1 mg/ml Intravenous Injection


NDC: 47351-017
Labeler: Onco Therapies Limited
Product Type: Human Prescription Drug
Drug Name:  Cladribine
Dosage Form: Intravenous Injection
Application #: ANDA200510
Rev. Date: 


NDC Package Codes:

  • 47351-017-10: 10 ML IN 1 VIAL (47351‑017‑10)

Active Ingredients:

  • Cladribine

Dosage Strength:

  • 1 mg/mL

Pharmaceutical Classes:

  • Purine Antimetabolite [EPC]

Related Products:

Based on records with the same trade name.
  • 0069-0086 Cladribine 1 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0201 Cladribine 1 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0143-9871 Cladribine 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 42658-010 Cladribine 1 mg/ml Intravenous Injection, Solution by Hisun Pharmaceuticals USA, Inc.
  • 63323-140 Cladribine 1 mg/ml Intravenous Injection by Fresenius Kabi USA, LLC
  • 67457-450 Cladribine 1 mg/ml Intravenous Injection by Mylan Institutional LLC
  • 67457-451 Cladribine 1 mg/ml Intravenous Injection by Mylan Institutional LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 47351-017 QR Code

< Prev: 47351-009Next: 47426-101 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.